2014 NIH SBIR & STTR Omnibus Grant Solicitation for Small Businesses
The 2014 SBIR and STTR Omnibus Grant Solicitation of the NIH is now live and the National Cancer Institute’s (NCI) budget for the program is increasing. Funding from the NCI Small Business Innovation Research & Small Business Tech Transfer (SBIR & STTR) Programs can help you advance your technology towards commercialization and can also help spark investor interest in your business.
The next application due date is April 5, 2014. We encourage you to start preparing your application and are happy to provide feedback on your project. If you’d like to take advantage of this opportunity, please email the NCI SBIR program director listed in your relevant technology area. Also be sure to check that all of your required registrations are complete. It’s never too early to start the registration process.
New changes in the 2014 Omnibus Solicitation include additional provisions of the 2011 SBIR & STTR Reauthorization Act, so please read the solicitations carefully.
- Applicants may now switch between SBIR & STTR Programs. Those who previously were funded under an STTR Phase I award are now eligible to apply for an SBIR Phase II award, and vice versa.
- Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms are eligible to apply to the NIH SBIR program. View frequently asked questions on VC participation.
View the Application Guide for NIH and Other PHS Agencies for more information on preparing and submitting SBIR & STTR applications.